Tokyo, May 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060867) titled 'Retrospective observational study evaluating the clinical utility of liquid biopsy in cancer genomic profiling for patients with non-small cell lung cancer: impact on treatment recommendation rates, treatment initiation rates, and patient characteristics' on May 10.
Study Type:
Observational
Primary Sponsor:
Institute - Tohoku University Hospital
Condition:
Condition - Non-small cell lung cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To evaluate the clinical utility of liquid biopsy-based cancer genomic profiling in patients with non-small cell lung cancer, specifically focusing on patient background factors that contribute to treatment recommendations and actual treatment delivery.
Basic objectives2 - Safety
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with non-small cell lung cancer aged 20 years or older at the time of testing, who underwent liquid biopsy-based cancer genomic profiling at Tohoku University Hospital between January 2019 and March 2026.
Key exclusion criteria - Patients judged inappropriate for the study by the principal or sub-investigator at each institution (e.g., due to a lack of essential clinical data required for analysis).
Patients who declined to participate in the study through the opt-out process.
Target Size - 50
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 03 Month 08 Day
Anticipated trial start date - 2026 Year 05 Month 10 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069654
Disclaimer: Curated by HT Syndication.
